Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.65, read 2026-11-05
Ethical screen not yet scored
Price5.13 USD
Fair value5.94
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-09-05Read Markdown8.68-40.9% to today ✓Distribution gives way to Markdown after a 10% rise in 4 weeks
2026-08-05Read Distribution7.90-35.1% to today ✓Markup gives way to Distribution after a 15% slide in 5 weeks
2026-07-02Read Markup9.34-45.1% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Mobileye Global Inc. holds its Distribution at $5.13. Consolidating, no directional conviction, held for 2 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 2 days
Price at the screen
$5.13
Valuation
N/A trailing · 10.96 forward price to earnings
Values screen
Not scored· score 70.0
Beta
1.30
The Workings
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
15.75%
Below 49%
Money owed to the company is 15.7% of assets, under the 49% limit.
Pass
Revenue purity
3.33%
Below 5%
Only 3.3% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
The Read, in Plain English
Mobileye Global clears the business-activity screen and the figures we can measure look clean, but its debt figure is still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 10% discount to our $5.94 fair value.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 13.6% discount to the base estimate.
Where our models see it going: fair-value estimate $5.94, with a range of $4.50 to $6.83, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Autonomous Driving Tech Still Drowns In Losses
Picture a chip that spots every pedestrian yet still cannot turn a profit on any mile driven. Mobileye shows 27% revenue growth and passes our ethical screen, yet forward earnings sit at 26.5 times while the firm posts a 204% negative profit margin and 41% negative return on equity. Fair value sits just 1% above the current price, leaving no real margin of safety and an opportunity rating of none.
Analyst chatter calls it a buy with an 11 dollar median target, but those numbers ignore the simple fact that heavy losses continue even as sales rise. The business splits between its core ADAS segment and the Moovit mobility app, yet neither has shown a path to consistent profits.
Currency moves, execution delays in China and the need to keep pouring cash into research keep the downside live. The market price already reflects most of the optimism on offer. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Israel and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MBLY trades on Nasdaq (the company is based in Israel). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markdown$5.59-22.3%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 22.3% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $13.
2026-10-28Markdown$7.19+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $13.
2026-10-21Markdown$7.19+1.3%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $13.
2026-10-14Markdown$7.10-3.4%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $13.
2026-10-02Markdown$7.35-15.3%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 15.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $13.
2026-09-05Markdown · changed$8.68+9.9%Entry 5
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 9.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $13.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $13.
2026-07-18Markup$9.22-1.3%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 1.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 43%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (29 analysts) rates it buy, with a mean price target of $13.
2026-07-03Markup$9.34+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$9.34Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
